BRM/BRG1 ATP Inhibitor-1 (BRM014) Mechanism of Action: SMARCA4 Inhibition in Cancer Cell Research

BRM/BRG1 ATP Inhibitor-1 (BRM014) MOA：Targeting SMARCA4/SWI/SNF Pathway for Oncology and Cancer Therapeutics

🎯 check BRM/BRG1 ATP Inhibitor-1 (BRM014) product page

BRM014 is a selective mutant EGFR PROTAC. It affects EGFR signaling, by CRBN-dependent degradation, to inhibit proliferation.

Primary Applications and Mechanism of Action

Jump to: